Zhang Li, Wu Juan, Ji Xueli, Chen Xufeng, Mei Yong, Huang Xihua
Department of Emergency Treatment, The First Affiliated Hospital of Nanjing Medical University Nanjing 210000, Jiangsu, China.
Am J Transl Res. 2025 Apr 15;17(4):2629-2641. doi: 10.62347/UQYS8766. eCollection 2025.
Veno-arterial extracorporeal membrane oxygenation (VA-ECMO) is vital for stabilizing patients with severe cardiac and pulmonary failure. Effective management requires precise monitoring of organ perfusion and systemic physiologic status. Near-infrared spectroscopy (NIRS) and ultrasound (US) are emerging as key methods of assessment, but their combined utility remains underexplored in VA-ECMO patients.
A retrospective analysis was conducted on 267 patients who received VA-ECMO between June 2018 and July 2023. Patients were divided into two groups based on weaning success, defined as survival for more than 48 hours post-weaning with improved cardiac function. Weaning trials involved incremental reductions in VA-ECMO flow, monitored by mean arterial pressure and other clinical measurements. Data including demographics, clinical scores [Glasgow Coma Scale (GCS), Acute Physiology and Chronic Health Evaluation II (APACHE II), Sequential Organ Failure Assessment (SOFA)], blood gas indicators, and NIRS and US metrics were collected and analyzed.
Significant differences were observed in cerebral regional oxygen saturation (rSO) dynamics and echocardiographic parameters between the groups. The successful group demonstrated higher maximal ΔrSO (29.57% ± 13.77) than the failure group (25.86% ± 6.39, = 0.003) and a lower minimal rSO (40.67% ± 15.87 vs. 43.9% ± 4.27, = 0.010). Post-ECMO, the successful group exhibited a higher cardiac index (CI, 2.47 L/min/m ± 0.74) compared to the failure group (2.26 L/min/m ± 0.61, = 0.018). Pre-weaning, the successful group displayed lower left ventricular ejection fraction (LVEF, 32.06% ± 4.64) versus the failure group (34.55% ± 8.45, = 0.016), yet post-weaning, it was higher (33.46% ± 4.85) than in the failure group (31.28% ± 7.37, = 0.017). Additionally, the left ventricular outflow tract velocity-time integral (LVOT-VTI) pre-weaning was significantly lower in the successful group (14.95 cm ± 2.98) compared to the failure group (17.35 cm ± 7.22, = 0.006).
NIRS and US were found to beconsistent and complementary modalities for assessing perfusion and cardiac function in VA-ECMO patients.
静脉-动脉体外膜肺氧合(VA-ECMO)对于稳定严重心肺功能衰竭患者至关重要。有效的管理需要精确监测器官灌注和全身生理状态。近红外光谱(NIRS)和超声(US)正逐渐成为关键的评估方法,但它们在VA-ECMO患者中的联合应用仍未得到充分探索。
对2018年6月至2023年7月期间接受VA-ECMO治疗的267例患者进行回顾性分析。根据撤机成功情况将患者分为两组,撤机成功定义为撤机后存活超过48小时且心功能改善。撤机试验包括逐步降低VA-ECMO流量,并通过平均动脉压和其他临床测量进行监测。收集并分析了包括人口统计学、临床评分[格拉斯哥昏迷量表(GCS)、急性生理与慢性健康状况评估II(APACHE II)、序贯器官衰竭评估(SOFA)]、血气指标以及NIRS和US指标在内的数据。
两组之间在脑区域氧饱和度(rSO)动态变化和超声心动图参数方面存在显著差异。成功组的最大ΔrSO(29.57% ± 13.77)高于失败组(25.86% ± 6.39,P = 0.003),最小rSO低于失败组(40.67% ± 15.87对43.9% ± 4.27,P = 0.010)。ECMO治疗后,成功组的心脏指数(CI,2.47 L/min/m² ± 0.74)高于失败组(2.26 L/min/m² ± 0.61,P = 0.018)。撤机前,成功组的左心室射血分数(LVEF,32.06% ± 4.64)低于失败组(34.55% ± 8.45,P = 0.016),但撤机后,成功组高于失败组(33.46% ± 4.85)(31.28% ± 7.37,P = 0.017)。此外,撤机前成功组的左心室流出道速度时间积分(LVOT-VTI)(14.95 cm ± 2.98)显著低于失败组(17.35 cm ± 7.22,P = 0.006)。
发现NIRS和US是评估VA-ECMO患者灌注和心功能的一致且互补的方式。